FDA expected to decide on AstraZeneca's self-administered flu vaccine next quarter
If all goes well at the FDA, AstraZeneca hopes to roll out the US’ first self-administered flu vaccine ahead of the next cold and flu …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
